69511-19-9 Usage
Description
3-heMisuccinate-25-hydroxyvitaMin D3, also known as 25-Hydroxyvitamin D3 3-Hemisuccinate, is a conjugate of 5-Hydroxyvitamin D3, which is the principal circulating form of vitamin D3. It is formed in the liver by hydroxylation at C-25 and plays a crucial role as a calcium regulator. 3-heMisuccinate-25-hydroxyvitaMin D3 is also utilized in the preparation and synthesis of antisera for the immunoassay of 25-Hydroxyvitamin D3.
Uses
Used in Calcium Regulation:
3-heMisuccinate-25-hydroxyvitaMin D3 is used as a calcium regulator for maintaining proper calcium levels in the body, which is essential for various physiological processes, including bone health and muscle function.
Used in Immunoassay:
In the field of medical diagnostics, 3-heMisuccinate-25-hydroxyvitaMin D3 is used as a key component in the preparation and synthesis of antisera. These antisera are specifically designed for the immunoassay of 25-Hydroxyvitamin D3, which is vital for assessing and monitoring the vitamin D3 levels in patients, aiding in the diagnosis and treatment of related health conditions.
Used in Pharmaceutical Industry:
Within the pharmaceutical industry, 3-heMisuccinate-25-hydroxyvitaMin D3 is used as an active pharmaceutical ingredient for the development of drugs targeting calcium-related disorders and vitamin D3 deficiency. Its role in calcium regulation makes it a valuable compound for creating therapeutic solutions to address various health issues.
Check Digit Verification of cas no
The CAS Registry Mumber 69511-19-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,5,1 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 69511-19:
(7*6)+(6*9)+(5*5)+(4*1)+(3*1)+(2*1)+(1*9)=139
139 % 10 = 9
So 69511-19-9 is a valid CAS Registry Number.
69511-19-9Relevant articles and documents
Release reagent for vitamin D compounds
-
Page/Page column 9, (2016/06/06)
The present invention concerns a reagent composition for releasing vitamin D compounds bound to vitamin D-binding protein, a method for the detection of a 25-hydroxyvitamin D compound in which the 25-hydroxyvitamin D compound is released from vitamin D-bi
